Last updated on October 2018

ADAPT - A Patient Registry of the Real-world Use of Orenitram


Brief description of study

This prospective, observational, multicenter, patient registry will follow patients who are receiving treatment with Orenitram for the treatment of PAH for up to 78 weeks from Orenitram initiation

Clinical Study Identifier: NCT03045029

Contact Investigators or Research Sites near you

Start Over

Anderson Pharmaceutical Research, LLC

Anderson, SC United States
9.42miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.